In step 7 of the immunity cycle, wherein T cells damage cancer cells, immune checkpoint molecules such as PD-1-expressing T cells and PD-ligand 1 (PD-L1)-expressing cancer cells act as co-inhibitors that suppress or halt T cell immune responses [64]. Here, PDCD1 is linked to cancer.